Form 8-K - Current report:
SEC Accession No. 0001558370-20-011192
Filing Date
2020-09-17
Accepted
2020-09-17 07:30:32
Documents
12
Period of Report
2020-09-17
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K kala-20200917x8k.htm   iXBRL 8-K 33441
  Complete submission text file 0001558370-20-011192.txt   153977

Data Files

Seq Description Document Type Size
2 EX-101.SCH kala-20200917.xsd EX-101.SCH 3016
3 EX-101.LAB kala-20200917_lab.xml EX-101.LAB 16033
4 EX-101.PRE kala-20200917_pre.xml EX-101.PRE 10626
5 EXTRACTED XBRL INSTANCE DOCUMENT kala-20200917x8k_htm.xml XML 4872
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

EIN.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 201180113
SIC: 2834 Pharmaceutical Preparations